TAFI activity in coronary artery disease: A contribution to the current discussion on TAFI assays

被引：19
|
作者：
Schroeder, Verena
Wilmer, Marianne
Buehler, Beatrice
Kohler, Hans P.
机构：
[1] Univ Hosp Bern, Inselspital, Lab Thrombosis Res, Dept Clin Res,Kinderklin G3, CH-3010 Bern, Switzerland
[2] Pentapharm Ltd, CH-4002 Basel, Switzerland
来源：
THROMBOSIS AND HAEMOSTASIS | 2006年 / 96卷 / 02期
关键词：
D O I：
10.1160/TH06-06-0295
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：236 / 237
页数：2
相关论文
共 50 条
  • [1] CHANGES IN ADMA AND TAFI AFTER STENTING IN CORONARY ARTERY DISEASE PATIENTS
    Khalifa, N.
    Gad, M.
    Hataba, A.
    Mahran, L.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S311 - S311
  • [2] CHANGES IN ADMA AND TAFI AFTER STENTING IN CORONARY ARTERY DISEASE PATIENTS
    Khalifa, N. M.
    Gad, M. Z.
    Hataba, A. A.
    Mahran, L. G.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S309 - S309
  • [3] Association of TAFI gene polymorphisms with severity of coronary stenosis in stable coronary artery disease
    Rattanawan, Chutima
    Komanasin, Nantarat
    Settasatian, Nongnuch
    Settasatian, Chatri
    Kukongviriyapan, Upa
    Intharapetch, Pongsak
    Senthong, Vichai
    THROMBOSIS RESEARCH, 2018, 171 : 171 - 176
  • [4] Changes in ADMA and TAFI levels after stenting in coronary artery disease patients
    Khalifa, Nouran M.
    Gad, Mohamed Z.
    Hataba, Alaa A.
    Mahran, Laila G.
    MOLECULAR MEDICINE REPORTS, 2012, 6 (04) : 855 - 859
  • [5] TAFI activity and antigen plasma levels are not increased in acute coronary artery disease patients admitted to a coronary care unit
    Cellai, Anna Paola
    Antonucci, Emilia
    Liotta, Agatina Alessandrello
    Fedi, Sandra
    Marcucci, Rossella
    Falciani, Michela
    Giglioli, Cristina
    Abbate, Rosanna
    Prisco, Domenico
    THROMBOSIS RESEARCH, 2006, 118 (04) : 495 - 500
  • [6] TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study
    Morange, PE
    Tregouet, DA
    Frere, C
    Luc, G
    Arveiler, D
    Ferrieres, J
    Amouyel, P
    Evans, A
    Ducimetiere, P
    Cambien, F
    Tiret, L
    Juhan-Vague, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (07) : 1503 - 1510
  • [7] Risk of coronary artery disease associated with thrombin activable fibrinolysis inhibitor (TAFI) levels
    Santamaria, A
    Martinez, A
    Oliver, A
    Tirado, I
    Borrell, M
    Mateo, J
    Souto, JC
    Fontcuberta, J
    EUROPEAN HEART JOURNAL, 2002, 23 : 566 - 566
  • [8] Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography
    Chatterjee, T
    Schroeder, V
    Fleisch, M
    Windecker, S
    Seiler, C
    Eberli, FR
    Meier, B
    Kohler, HP
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 204A - 204A
  • [9] Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography
    Schroeder, V
    Chatterjee, T
    Mehta, H
    Windecker, S
    Pham, T
    Devantay, N
    Meier, B
    Kohler, HP
    THROMBOSIS AND HAEMOSTASIS, 2002, 88 (06) : 1020 - 1025
  • [10] STUDIES OF THE CORRELATION OF THE TAFI GENE WITH ARTERIAL HYPERTENSION IN PATIENTS WITH CORONARY HEART DISEASE
    Zokirova, Muborakhon
    JOURNAL OF HYPERTENSION, 2023, 41 : E177 - E177
12345